InvestSMART

Immuron Limited (ASX: IMC) - Announcements

- Current share price for IMC : $0.037

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$12 Appendix 3B for Rights Issue & New Top 20 Shareholder List 7 Jul 2016 11:59AM $0.250 $0.037 fallen by 85.20%
$12 Immuron Rights Issue Raises $5.33M 5 Jul 2016 3:40PM $0.250 $0.037 fallen by 85.20%
$12 IMC Signs Shigella Vaccine Developmt Agreement with US Army 21 Jun 2016 9:36AM $0.260 $0.037 fallen by 85.77%
$12 Immuron Newsletter - June 2016 20 Jun 2016 12:05PM $0.255 $0.037 fallen by 85.49%
$12 Travelan and Protectyn Are Now Available For Sale in China 16 Jun 2016 9:40AM $0.245 $0.037 fallen by 84.90%
$12 Immuron Extends Closing Date of $6M Rights Issue 14 Jun 2016 4:30PM $0.245 $0.037 fallen by 84.90%
$12 Travelan to Reach Upto 1.5M New US Customers via Magellans 14 Jun 2016 10:11AM $0.245 $0.037 fallen by 84.90%
$12 Immuron Company Presentation - May 2016 31 May 2016 10:12AM $0.330 $0.037 fallen by 88.79%
$12 Immuron Rights Issue Offer Booklet (May 2016) 31 May 2016 10:11AM $0.330 $0.037 fallen by 88.79%
$12 Letter to Ineligible Shareholders Regarding Rights Issue 31 May 2016 10:04AM $0.330 $0.037 fallen by 88.79%
$12 Letter to Eligible Shareholders Regarding Rights Issue 31 May 2016 10:03AM $0.330 $0.037 fallen by 88.79%
$12 Letter to Optionholders Regarding Rights Issue (May 2016) 31 May 2016 10:02AM $0.330 $0.037 fallen by 88.79%
$12 Section 708AA Notice (Rights Issue) 31 May 2016 10:00AM $0.330 $0.037 fallen by 88.79%
$12 Appendix 3B & 708A Notice 31 May 2016 9:58AM $0.330 $0.037 fallen by 88.79%
$12 Immuron Announces $6M Rights Issue Offer 31 May 2016 9:58AM $0.330 $0.037 fallen by 88.79%
$12 Trading halt 27 May 2016 9:08AM $0.330 $0.037 fallen by 88.79%
$12 NASH Phase II Trial Reaches 50% Recruitment Milestone 25 May 2016 11:23AM $0.305 $0.037 fallen by 87.87%
$12 Appendix 3B & 708A Notice 16 May 2016 5:54PM $0.335 $0.037 fallen by 88.96%
$12 Immuron Announces E-Commerce Agreement with QBID in China 9 May 2016 9:30AM $0.340 $0.037 fallen by 89.12%
$12 US Distribution Reach Expanded through McKesson 28 Apr 2016 9:34AM $0.365 $0.037 fallen by 89.86%
$12 US Travelan Sales Network Widened by Allocation Inc Ptnrship 19 Apr 2016 9:32AM $0.330 $0.037 fallen by 88.79%
$12 Appendix 3B & 708A Notice 18 Apr 2016 6:30PM $0.330 $0.037 fallen by 88.79%
$12 Expansion of US Travelan Sales Following CVS Pharmacy Launch 14 Apr 2016 9:57AM $0.340 $0.037 fallen by 89.12%
$12 Appendix 3B - Issuance of Securities 13 Apr 2016 7:17PM $0.340 $0.037 fallen by 89.12%
$12 Appendix 4D - Half Yearly Report and Accounts 25 Feb 2016 2:40PM $0.390 $0.037 fallen by 90.51%

626 - 650 of 790 results

Page 26 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.